Bundesinstitut für Arzneimittel und Medizinprodukte — Lieferengpässe (BfArM)
Bundesinstitut für Arzneimittel und Medizinprodukte — Lieferengpässe is the official source of medicine shortage information for Germany (EU). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.bfarm.de
- Country
- Germany
- Notices tracked by Mederti
- 957
- Last checked
- 16 Sept 2026
Latest notices from BfArM
- Esmololhydrochlorid — active, high, since 1 May 2027 (source)
- Etoricoxib — active, medium, since 4 Dec 2026 (source)
- Encorafenib — active, medium, since 16 Nov 2026 (source)
- Midodrinhydrochlorid — active, medium, since 27 Oct 2026 (source)
- Binimetinib — active, medium, since 28 Sept 2026 (source)
- Olanzapinembonat-Monohydrat — active, high, since 19 Sept 2026 (source)
- Pankreas-Pulver Vom Schwein — active, medium, since 10 Sept 2026 (source)
- Isotretinoin — active, medium, since 9 Sept 2026 (source)
- Olanzapinembonat-Monohydrat — active, high, since 8 Sept 2026 (source)
- Trofosfamid — active, high, since 3 Sept 2026 (source)
- Olanzapin — active, high, since 3 Sept 2026 (source)
- Cilostazol — active, medium, since 2 Sept 2026 (source)
- Tacrolimus — active, medium, since 2 Sept 2026 (source)
- Buprenorphin — active, medium, since 2 Sept 2026 (source)
- Cytarabin — active, medium, since 2 Sept 2026 (source)
Every BfArM notice, searchable and alertable
Search Germany's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Bundesinstitut für Arzneimittel und Medizinprodukte — Lieferengpässe. All notices remain the property of their publisher and are linked to the original source.